Last reviewed · How we verify
oral anticoagulation
oral anticoagulation is a Small molecule drug developed by Deutsches Herzzentrum Muenchen. It is currently FDA-approved. Also known as: Citrate, warfarin, Vitamin K Antagonists or Direct Oral Anticoagulants.
Oral anticoagulation is used to treat conditions such as venous thromboembolism, atrial fibrillation, and coronary artery disease. It involves the use of medications like apixaban, edoxaban, rivaroxaban, and dabigatran, which are direct oral anticoagulants (DOACs) that work by inducing an immune response.
At a glance
| Generic name | oral anticoagulation |
|---|---|
| Also known as | Citrate, warfarin, Vitamin K Antagonists or Direct Oral Anticoagulants |
| Sponsor | Deutsches Herzzentrum Muenchen |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure (PHASE4)
- OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation (PHASE4)
- SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation
- Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia (PHASE4)
- Shared Decision Making to Address Racial Disparities in Oral Anticoagulation in NVAF (NA)
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (NA)
- A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF (PHASE4)
- A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- oral anticoagulation CI brief — competitive landscape report
- oral anticoagulation updates RSS · CI watch RSS
- Deutsches Herzzentrum Muenchen portfolio CI
Frequently asked questions about oral anticoagulation
What is oral anticoagulation?
Who makes oral anticoagulation?
Is oral anticoagulation also known as anything else?
What development phase is oral anticoagulation in?
Related
- Manufacturer: Deutsches Herzzentrum Muenchen — full pipeline
- Also known as: Citrate, warfarin, Vitamin K Antagonists or Direct Oral Anticoagulants
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing